EFFICACY AND SAFETY OF FORMOTEROL IN CHILDREN WITH BRONCHIAL ASTHMA EXACERBATIONS

<em>Efficacy and safety of long acting 29 agonist formoterol (foradil aerolizer) was investigated in comparative study. 30 pediatric patients (6-16 years old) with bronchial asthma were treated with formoterol. 100 ?g of salbutamol by metered9dose inhaler was administered to control group of c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: S.V. Zaitseva (VerfasserIn), O.V. Zaitseva (VerfasserIn), N.V. Aleksandrina (VerfasserIn), T.V. Praznikova (VerfasserIn), T.I. Rychkova (VerfasserIn), S.I. Bardennikova (VerfasserIn), E.V. Kulikova (VerfasserIn), O.B. Dovgun (VerfasserIn), M.A. Kazantseva (VerfasserIn), O.B. Voronina (VerfasserIn), T.P. Rubtsova (VerfasserIn)
Format: Buch
Veröffentlicht: "Paediatrician" Publishers LLC, 2008-01-01T00:00:00Z.
Schlagworte:
Online-Zugang:Connect to this object online.
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_87cbb5f55e084f0ab92c17baef1e910c
042 |a dc 
100 1 0 |a S.V. Zaitseva  |e author 
700 1 0 |a O.V. Zaitseva  |e author 
700 1 0 |a N.V. Aleksandrina  |e author 
700 1 0 |a T.V. Praznikova  |e author 
700 1 0 |a T.I. Rychkova  |e author 
700 1 0 |a S.I. Bardennikova  |e author 
700 1 0 |a E.V. Kulikova  |e author 
700 1 0 |a O.B. Dovgun  |e author 
700 1 0 |a M.A. Kazantseva  |e author 
700 1 0 |a O.B. Voronina  |e author 
700 1 0 |a T.P. Rubtsova  |e author 
245 0 0 |a EFFICACY AND SAFETY OF FORMOTEROL IN CHILDREN WITH BRONCHIAL ASTHMA EXACERBATIONS 
260 |b "Paediatrician" Publishers LLC,   |c 2008-01-01T00:00:00Z. 
500 |a 1682-5527 
500 |a 1682-5535 
520 |a <em>Efficacy and safety of long acting 29 agonist formoterol (foradil aerolizer) was investigated in comparative study. 30 pediatric patients (6-16 years old) with bronchial asthma were treated with formoterol. 100 ?g of salbutamol by metered9dose inhaler was administered to control group of children (n = 30). The bronchodilating effect of formoterol was comparable to that of short acting 29 agonist salbutamol. Maximal bronchodilating action was registered in 2-4 hours after inhalation and lasted out more then 12 hours. For moterol aerolizer can be easily applicated and allows to carry out doctor's recommendations and to increase the effectiveness of treatment. Formoterol aerolizer allows making greatly less mistakes in inhalation technique then salbutamol in metered dose inhaler. Authors made a conclusion that for moterol can be used as a rescue treatment in children with bronchial asthma upwards 5 years old treated with appropriate basis regimens.</em><br /><em><strong>Key words: children, bronchial asthma, formoterol, aerolizer.</strong></em> 
546 |a EN 
546 |a RU 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Вопросы современной педиатрии, Vol 7, Iss 5, Pp 46-50 (2008) 
787 0 |n http://vsp.spr-journal.ru:80/jour/article/view/1456 
787 0 |n https://doaj.org/toc/1682-5527 
787 0 |n https://doaj.org/toc/1682-5535 
856 4 1 |u https://doaj.org/article/87cbb5f55e084f0ab92c17baef1e910c  |z Connect to this object online.